Researchers tracked 554 TAVR programs that opened from 2012 to 2018, sharing their findings at the SCAI 2021 Scientific Sessions.

Researchers presented new data from the North American COVID-19 Myocardial Infarction registry, detailing the ongoing pandemic's "deadly impact." 

The new guidelines were endorsed by the American College of Cardiology, American Heart Association, Heart Rhythm Society and Clinical Policy Approval Committee.

Researchers explored data from one arm of the MITRAL early feasible study, sharing their findings in JACC: Cardiovascular Interventions. 

Researchers explored data from the COAPT trial, sharing their findings in JACC: Cardiovascular Interventions.

PQ Bypass, the company Endologix acquired, has gained significant attention for its Detour platform, an investigational treatment for percutaneous femoral-popliteal bypass.

The Heart Failure Association, European Association of Cardiovascular Imaging, European Heart Rhythm Association and European Association of Percutaneous Cardiovascular Interventions all collaborated on the position statement.

Improving access is at the center of a pair of new trends in treating peripheral artery disease (PAD). First is the office-based lab (OBL) expanding access to more PAD patients needing therapy, and the second is physicians more often choosing alternative access such as radial, tibial or pedal to treat those patients. Why now?